Repository logo
 
Publication

Rhuepo induced-hypertension leads to early renal damage

dc.date.accessioned2015-03-23T16:09:53Z
dc.date.available2015-03-23T16:09:53Z
dc.date.issued2014
dc.description.abstractIntroduction and aims: The introduction of recombinant human erythropoietin (rHuEpo) improved the treatment of anemia in chronic kidney disease patients. However, in the recent years, some concerns were raised about this therapy, namely the development of cardiovascular complications, one of the major causes of death in the patients. Hypertention development is closely associated with renal deterioration and is one of the most described side effects associated with rHuEpo therapy. The aim of this study was to assess the effect of rHuEpo-induced hypertension on renal function and lesions, using an animal model.por
dc.identifier.citationSandra Ribeiro, João Fernandes, Patrícia Garrido, José Sereno, Helena Vala, Elsa Bronze da Rocha, Luís Belo, Elísio Costa, Flávio Reis and Alice Santos-Silva (2014). Rhuepo induced-hypertension leads to early renal damage. Nephrol. Dial. Transplant, 29 (suppl 3): iii79-iii89por
dc.identifier.urihttp://hdl.handle.net/10400.19/2733
dc.language.isoengpor
dc.peerreviewedyespor
dc.subjectanemiapor
dc.subjectrecombinant human erythropoietin (rHuEpo)por
dc.subjectchronic kidney diseasepor
dc.titleRhuepo induced-hypertension leads to early renal damagepor
dc.typeconference object
dspace.entity.typePublication
oaire.citation.endPageiii89por
oaire.citation.startPageiii79por
oaire.citation.titleNephrol. Dial. Transplantpor
oaire.citation.volume29 (suppl 3)por
rcaap.rightsrestrictedAccesspor
rcaap.typeconferenceObjectpor

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
49 RHUEPO INDUCED-HYPERTENSION Ribeiro et al 14.pdf
Size:
1.48 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Item-specific license agreed upon to submission
Description: